Back to Search
ILA SEHGAL, D.O.
D.O.
Pediatrics Physician
NPI: 1942735980Individual
Specialties, Licenses & Credentials
Pediatrics PhysicianPrimary
Pediatrics
Code: 208000000X
BP10059356(TX)
Research & Publications (16)
Photoinduced cytotoxicity and biodistribution of prostate cancer cell-targeted porphyrins.
PMID 18839477·J Med Chem·2008
7-preclinical
Effective treatment of human breast tumor in a mouse xenograft model with herpes simplex virus type 1 specifying the NV1020 genomic deletion and the gBsyn3 syncytial mutation enabling high viral replication and spread in breast cancer cells.
PMID 17536976·Hum Gene Ther·2007
7-preclinical
A doxycycline-inducible urokinase receptor (uPAR) upregulates uPAR activities including resistance to anoikis in human prostate cancer cell lines.
PMID 17509140·Mol Cancer·2007
8-other
Immunohistochemical staining of urokinase plasminogen activator-like and urokinase plasminogen activator receptor-like proteins in the urinary tract of healthy dogs.
PMID 16948613·Am J Vet Res·2006
7-preclinical
Prostate cancer cells show elevated urokinase receptor in a mouse model of metastasis.
PMID 16928272·Cancer Cell Int·2006
8-other
The superoxide scavenger TEMPOL induces urokinase receptor (uPAR) expression in human prostate cancer cells.
PMID 16756681·Mol Cancer·2006
8-other
Structure-function studies of the functional and binding epitope of the human 37 kDa laminin receptor precursor protein.
PMID 15946191·J Pept Res·2005
8-other
Aryl hydrocarbon exposure induces expression of MMP-9 in human prostate cancer cell lines.
PMID 15922868·Cancer Lett·2005
8-other
PTEN promoter is methylated in a proportion of invasive breast cancers.
PMID 15382065·Int J Cancer·2004
8-other
Increased levels of urokinase plasminogen activator receptor in prostate cancer cells derived from repeated metastasis.
PMID 15052500·World J Urol·2004
7-preclinical
Lycopene increases urokinase receptor and fails to inhibit growth or connexin expression in a metastatically passaged prostate cancer cell line: a brief communication.
PMID 12968069·Exp Biol Med (Maywood)·2003
4-observational
Growth factor regulation of secreted matrix metalloproteinase and plasminogen activators in prostate cancer cells, normal prostate fibroblasts and normal osteoblasts.
PMID 12806374·Prostate Cancer Prostatic Dis·2003
7-preclinical
Stability of multidose, preserved formulation epoetin alfa in syringes for three and six weeks.
PMID 12635452·Am J Health Syst Pharm·2003
8-other
Paracrine communication between malignant and non-malignant prostate epithelial cells in culture alters growth rate, matrix protease secretion and in vitro invasion.
PMID 12553379·Clin Exp Metastasis·2002
8-other
Inhibition of murine prostate tumor growth and activation of immunoregulatory cells with recombinant canarypox viruses.
PMID 11438565·J Natl Cancer Inst·2001
7-preclinical
Dietary 4-HPR suppresses the development of bone metastasis in vivo in a mouse model of prostate cancer progression.
PMID 11467776·Clin Exp Metastasis·2000
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4900 MUELLER BLVD STE 3S.066C
AUSTIN, TX 78723 - Phone
- (512) 324-0165
Quick Facts
- NPI
- 1942735980
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 16
Are you this provider?
Claim Your Profile